Learn more

ALBANY MOLECULAR RES INC

Overview
  • Total Patents
    305
  • GoodIP Patent Rank
    69,984
  • Filing trend
    ⇩ 100.0%
About

ALBANY MOLECULAR RES INC has a total of 305 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1994. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AMR TECHNOLOGY INC, CYTOPIA RES PTY LTD and BURGEY CHRISTOPHER S.

Patent filings per year

Chart showing ALBANY MOLECULAR RES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Liu Shuang 56
#2 Guzzo Peter R 56
#3 Molino Bruce F 53
#4 Manning David D 45
#5 Surman Matthew David 40
#6 D Ambra Thomas E 39
#7 Guzzo Peter 35
#8 Nacro Kassoum 32
#9 Henderson Alan John 30
#10 Hadden Mark 30

Latest patents

Publication Filing date Title
WO2020023435A1 Venetoclax basic salts and processes for the purification of venetoclax
EP3412666A1 Process and intermediates for the preparation of bcl-2 inhibitors including venetoclax through reductive amination
US2017157116A1 Methods and compositions for preventing opioid abuse
US2018134724A1 Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
AU2014201996A1 Pyridazinone derivatives useful as glucan synthase inhibitors
WO2014160305A1 Ligand-therapeutic agent conjugates and silicon-based linkers
US2014163012A1 Pyrido-/azepino-benzofuran and pyrido-/azepino-benzothiophene mch-1 antagonists, methods of making, and use thereof
AU2012202570A1 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2012201041A1 Process for production of delta-9-tetrahydrocannabinol
AU2012207335A1 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2012088038A2 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
EP2606049A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2011276265A1 Novel antibacterial compounds, methods of making them, and uses thereof
WO2011153359A1 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2011044134A1 Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
EP2448585A1 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof